DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1Olpha
03 6Granules India Limited
04 2Adamed Pharma
05 1Alhavi Pharma
06 2Alkem Laboratories
07 2Annora Pharma
08 1Aurobindo Pharma Limited
09 40Boehringer Ingelheim GmbH
10 6Farmaprojects S.A.U
11 3Grupo Azevedos
12 4Intas Pharmaceuticals
13 1InvaGen Pharmaceuticals Inc
14 2Kinapse
15 3Laboratorios Lafage
16 2MSN Laboratories
17 1Mahban Group
18 4Pharmaline
19 3Pluviaendo
20 3Prinston
21 3Sun Pharmaceutical Industries Limited
22 4Sunshine Lake Pharma
23 2Tecnimede
24 3Varian Pharmed
25 3Viatris
26 4XYZ Pharma
27 4Zentiva
28 4Zydus Pharmaceuticals
01 6Antic-calc Tablet, Film Coated
02 3Each Coated Tablet
03 3FILM COATED PILL
04 14Film Coated Tablet
05 4Film Coated Tablet
06 3Filmtabl
07 7Filmtable
08 6Immediate Release Tablet
09 1Linagliptin 5Mg 28 Combined Oral Use
10 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
11 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
12 4Oral Solid Dosage Form
13 4TABLET
14 6TABLET, EXTENDED RELEASE;ORAL
15 4TABLET; ORAL
16 33TABLET;ORAL
17 11Tablet
18 2Tablets
19 1Tablets
20 2tablet
21 2Blank
01 4DISCN
02 1Dossier Readiness: Q1 2025
03 2Generic
04 4Lead Market Dossiers- Filed
05 17RX
06 90Blank
01 1Diagliptin Deo
02 3EMPAGLIFLOZIN AND LINAGLIPTIN
03 6EMPAGLIFLOZIN; LINAGLIPTIN
04 2Empagliflozin ; Linagliptin
05 1Empiria Complex
06 1Empiria Complex
07 2GLYXAMBI
08 2Glyxambi
09 6JENTADUETO
10 2JENTADUETO XR
11 14Jentadueto
12 5LINAGLIPTIN
13 1LINAGLIPTIN 5
14 14LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
15 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
16 1Linagliptin
17 3Linagliptin ; Metformin Hydrochloride
18 1Melijent
19 1TRADJENTA
20 1TRAJENTA
21 4TRIJARDY XR
22 8Trajenta
23 36Blank
01 2Australia
02 4Canada
03 4Czech Republic
04 3Guatemala
05 14India
06 5Iran
07 3Italy
08 1Latvia
09 4Lebanon
10 6Norway
11 2Poland
12 5Portugal
13 6Spain
14 3Sweden
15 10Switzerland
16 3Turkey
17 43USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 10MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 25MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2016-05-27
Application Number : 208026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG;1GM
Packaging :
Approval Date : 2016-05-27
Application Number : 208026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-08-31
Application Number : 208335
Regulatory Info : RX
Registration Country : USA
